Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Digestive Diseases and Sciences
|
February 28, 2018
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
Mark Fleisher, Jan Marsal, Scott D Lee, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease
Anita Afzali, Christopher J Park, Kehao Zhu, et al.
BMC Gastroenterology
|
February 9, 2023
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
Scott D Lee, Jessica R Allegretti, Flavio Steinwurz, et al.
Journal of Clinical Gastroenterology
|
August 3, 2020
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
Scott D Lee, Raina Shivashankar, Daniel Quirk, et al.
The American Journal of Gastroenterology
|
March 13, 2025
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study
Scott D Lee, Severine Vermeire, Ryan Ungaro, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
August 4, 2023
Relationship of Sleep Health and Endoscopic Disease Activity in Inflammatory Bowel Disease: Endoscopic Disease Activity and Sleep
Kendra J Kamp, Linda Yoo, Kindra Clark-Snustad, et al.
Gastrointestinal Endoscopy
|
December 7, 2007
Complications after ERCP in patients with primary sclerosing cholangitis
Jason P Etzel, Sue C Eng, Cynthia W Ko, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.
Crohn'S & Colitis 360
|
February 3, 2025
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry
Gary R Lichtenstein, Scott D Lee, Brian G Feagan, et al.
Inflammatory Bowel Diseases
|
April 18, 2012
Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines
Timothy L Zisman, Mary P Bronner, Stephen Rulyak, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Digestive Diseases and Sciences
|
February 28, 2018
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
Mark Fleisher, Jan Marsal, Scott D Lee, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease
Anita Afzali, Christopher J Park, Kehao Zhu, et al.
BMC Gastroenterology
|
February 9, 2023
Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
Scott D Lee, Jessica R Allegretti, Flavio Steinwurz, et al.
Journal of Clinical Gastroenterology
|
August 3, 2020
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
Scott D Lee, Raina Shivashankar, Daniel Quirk, et al.
The American Journal of Gastroenterology
|
March 13, 2025
Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study
Scott D Lee, Severine Vermeire, Ryan Ungaro, et al.
Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates
|
August 4, 2023
Relationship of Sleep Health and Endoscopic Disease Activity in Inflammatory Bowel Disease: Endoscopic Disease Activity and Sleep
Kendra J Kamp, Linda Yoo, Kindra Clark-Snustad, et al.
Gastrointestinal Endoscopy
|
December 7, 2007
Complications after ERCP in patients with primary sclerosing cholangitis
Jason P Etzel, Sue C Eng, Cynthia W Ko, et al.
Alimentary Pharmacology & Therapeutics
|
October 21, 2022
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials
Laurent Peyrin-Biroulet, Subrata Ghosh, Scott D Lee, et al.
Crohn'S & Colitis 360
|
February 3, 2025
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry
Gary R Lichtenstein, Scott D Lee, Brian G Feagan, et al.
Inflammatory Bowel Diseases
|
April 18, 2012
Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines
Timothy L Zisman, Mary P Bronner, Stephen Rulyak, et al.
Page
of 5